FORM C | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Form C: Filer Information
Filer CIK: | 0001759355 |
Filer CCC: | XXXXXXXX |
File Number: | 020-25058 |
Period: | 12-31-2020 |
Is this a LIVE or TEST Filing? | LIVE TEST |
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | |
Would you like a Return Copy? |
Submission Contact Information
Name: | |
Phone Number: | |
Contact E-Mail Address: | |
Notify via Filing Website only? |
Form C: Issuer Information
Issuer Information
Name of Issuer: | Pluton Biosciences, Incorporated |
Legal Status of Issuer:
Form: | Corporation |
Jurisdiction of Incorporation/Organization: | MISSOURI |
Date of Incorporation/Organization: | 01-16-2017 |
Physical Address of Issuer:
Address 1: | 11754 Westline Industrial Drive |
City: | St. Louis |
State/Country: | MISSOURI |
Mailing Zip/Postal Code: | 63146 |
Website of Issuer: | https://plutonbio.com |
Form C: Offering Information
Offering Information
Form C: Annual Report Disclosure Requirements
Annual Report Disclosure Requirements
Current Number of Employees: | 15 |
Total Assets Most Recent Fiscal Year-end: | 709402.00 |
Total Assets Prior Fiscal Year-end: | 557425.00 |
Cash and Cash Equivalents Most Recent Fiscal Year-end: | 191989.00 |
Cash and Cash Equivalents Prior Fiscal Year-end: | 14567.00 |
Accounts Receivable Most Recent Fiscal Year-end: | 53280.00 |
Accounts Receivable Prior Fiscal Year-end: | 22785.00 |
Short-term Debt Most Recent Fiscal Year-end: | 23514.00 |
Short-term Debt Prior Fiscal Year-end: | 0.00 |
Long-term Debt Most Recent Fiscal Year-end: | 1282531.00 |
Long-term Debt Prior Fiscal Year-end: | 1168878.00 |
Revenue/Sales Most Recent Fiscal Year-end: | 476675.00 |
Revenue/Sales Prior Fiscal Year-end: | 19431.00 |
Cost of Goods Sold Most Recent Fiscal Year-end: | 188857.00 |
Cost of Goods Sold Prior Fiscal Year-end: | 6627.00 |
Taxes Paid Most Recent Fiscal Year-end: | 0.00 |
Taxes Paid Prior Fiscal Year-end: | 0.00 |
Net Income Most Recent Fiscal Year-end: | -979712.00 |
Net Income Prior Fiscal Year-end: | -388.82 |
Form C: Signature
Signature
Issuer: | Pluton Biosciences, Incorporated |
Signature: | Charlie Walch |
Title: | CBO |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Charlie Walch |
Title: | CBO, Co-Founder |
Date: | 04-30-2021 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
Signature: | Barry Goldman |
Title: | CEO and Chief Scientific Officer, Co-Founder |
Date: | 04-30-2021 |